Brief: Evoke Pharma Reports First Quarter 2021 Financial Results
May 12 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.08
* AS OF MARCH 31, 2021, COMPANY'S CASH AND CASH EQUIVALENTS
WERE
APPROXIMATELY $18.2 MILLION
* EXPECT SUFFICIENT RUNWAY TO FUND OUR OPERATIONS INTO Q1 OF
2022.
Source text for Eikon: ID:nGNX17TLpW
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary